VAXCYTE INC. - COMMON

Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update

11 5 2021 15:10:00 提供 Nasdaq GlobeNewswire

Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease

10 5 2021 07:30:00 提供 Nasdaq GlobeNewswire

Vaxcyte to Present at BofA Securities 2021 Health Care Conference

06 5 2021 15:05:02 提供 Nasdaq GlobeNewswire

Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference

05 4 2021 15:30:00 提供 Nasdaq GlobeNewswire

Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

29 3 2021 15:10:00 提供 Nasdaq GlobeNewswire

Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

22 3 2021 15:05:00 提供 Nasdaq GlobeNewswire

Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections

06 1 2021 07:15:00 提供 Nasdaq GlobeNewswire